51111610 Methotrexate

Definition

UNSPSC 51111610

This classification denotes a folate antagonist and dihydrofolate reductase inhibitor with the molecular formula C20H22N8O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YL5FZ2Y5U1, chemically known as poly(imino((1s)-1-carboxy-4-oxo-1,4-butanediyl)), alpha-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-omega-hydroxy- but generally known as methotrexate, which bears US NIH Compound Identifier 4112. European Medicines Agency schedules Methotrexate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08856MIG. The term METHOTREXATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules methotrexate in its Anatomical Therapeutic Chemical (ATC) Classification. METHOTREXATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule methotrexate under HS 29335995 and SITC 51576. As of Q4 2014, METHOTREXATE remains the US FDA Preferred Term for this commodity. Methotrexate bears US NLM identifiers UMLS ID C0025677 and NCI Concept Code C642. SMILES: OC(=O)C(NC(=O)C1CCC(N(CC2NC3C(NC2)NC(NC3N)N)C)CC1)CCC(=O)O.

Same parent

Under 51111600 · 55

51111602 Cytarabine Commodity 51111603 Floxuridine Commodity 51111606 Hydroxycarbamide or hydroxyurea Commodity 51111610 Methotrexate You are here 51111611 Teniposide Commodity 51111613 Lenograstim Commodity 51111615 Glutathione Commodity 51111617 Gemcitabine Commodity 51111619 Brequinar Commodity 51111620 Acadesine Commodity 51111621 Acivicin Commodity 51111622 Adenine Commodity 51111623 Amonafide Commodity 51111624 Ancitabine Commodity 51111625 Azacitidine Commodity 51111626 Bexarotene Commodity 51111627 Doxifluridine Commodity 51111628 Carmofur Commodity 51111629 Clofarabine Commodity 51111630 Decitabine Commodity 51111631 Dezaguanine Commodity 51111632 Diflomotecan Commodity 51111633 Edatrexate Commodity 51111634 Emitefur Commodity 51111635 Eniluracil Commodity 51111636 Enocitabine Commodity 51111637 Evandamine Commodity 51111638 Exatecan Commodity 51111639 Fazarabine Commodity 51111640 Masoprocol Commodity 51111641 Galocitabine Commodity 51111642 Irinotecan Commodity 51111643 Ketotrexate Commodity 51111644 Lonidamine Commodity 51111645 Pralatrexate Commodity 51111646 Nelarabine Commodity 51111647 Nolatrexed Commodity 51111648 Oteracil Commodity 51111649 Peldesine Commodity 51111650 Pemetrexed Commodity 51111651 Pirazofurin or pyrazofurin Commodity 51111652 Piritrexim Commodity 51111653 Tocladesine Commodity 51111654 Raltitrexed Commodity 51111655 Rubitecan Commodity 51111656 Tegafur Commodity 51111657 Tezacitabine Commodity 51111658 Tiazofurin or tiazofurine Commodity 51111659 Topotecan Commodity 51111660 Triciribine Commodity 51111661 Troxacitabine Commodity 51111662 Uracil Commodity 51111663 Valopicitabine Commodity 51111664 Aminopterin Commodity 51111665 Thioguanine or tioguanine Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 51110000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class